Literature DB >> 28464368

Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.

Daniel M Harrison1, Kevin Y Wang2, Julie Fiol3, Kerry Naunton1, Walter Royal1, Jun Hua4,5, Izlem Izbudak4.   

Abstract

BACKGROUND AND
PURPOSE: Perform an investigation of the frequency and distribution of leptomeningeal enhancement on postgadolinium magnetization-prepared FLAIR (MPFLAIR) in multiple sclerosis (MS) on 7 Tesla (7T) MRI and to relate this finding to measures of brain structure and lesion volumes.
METHODS: Twenty-nine participants with MS underwent 7T MRI of the brain. Three healthy volunteers (HVs) were scanned for comparison. Areas of postcontrast leptomeningeal enhancement were identified. Images were segmented for brain structure and lesion volumes. The relationship between leptomeningeal enhancement and clinical and volumetric data was explored.
RESULTS: Two patterns of enhancement were found: "nodular" (discrete, spherical nodules at the pial surface or subarachnoid space) and "spread/fill" (appearance of contrast spread through the local subarachnoid space). Twenty-six of 29 (90%) MS participants had at least one focus of leptomeningeal enhancement. Nodular foci were present in 15 of 29 (51%) MS participants. Spread/fill foci were present in 22 of 29 (76%) MS participants. Two HVs had examples of nodular foci, but none had spread/fill enhancement. MS participants with spread/fill foci were older (48.9 years [SD 8.3]) than those without (33.3 years [SD 11.5], P = .005). MS participants with spread/fill foci had reduced cortical gray matter volume compared to those without (P = .020).
CONCLUSIONS: Leptomeningeal enhancement on postcontrast 7T MPFLAIR is more prevalent than prior reports at 3T-occurring at frequencies closer to histopathologic data. Spread/fill foci are associated with reduced cortical gray matter volumes and may represent blood-meningeal barrier breakdown near sites of meningeal inflammation, whereas nodular foci may be a normal variant.
Copyright © 2017 by the American Society of Neuroimaging.

Entities:  

Keywords:  7 Tesla; Multiple sclerosis; meningeal; meningeal enhancement; meningeal inflammation; ultra-high field MRI

Mesh:

Year:  2017        PMID: 28464368      PMCID: PMC5581238          DOI: 10.1111/jon.12444

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  38 in total

1.  Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

Authors:  P Flachenecker; T Kümpfel; B Kallmann; M Gottschalk; O Grauer; P Rieckmann; C Trenkwalder; K V Toyka
Journal:  Mult Scler       Date:  2002-12       Impact factor: 6.312

2.  A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.

Authors:  Roberta Magliozzi; Owain W Howell; Cheryl Reeves; Federico Roncaroli; Richard Nicholas; Barbara Serafini; Francesca Aloisi; Richard Reynolds
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

3.  New high dielectric constant materials for tailoring the B1+ distribution at high magnetic fields.

Authors:  K Haines; N B Smith; A G Webb
Journal:  J Magn Reson       Date:  2010-01-11       Impact factor: 2.229

4.  A computational framework for ultra-high resolution cortical segmentation at 7Tesla.

Authors:  Pierre-Louis Bazin; Marcel Weiss; Juliane Dinse; Andreas Schäfer; Robert Trampel; Robert Turner
Journal:  Neuroimage       Date:  2013-04-25       Impact factor: 6.556

5.  Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.

Authors:  Kevin Blauth; John Soltys; Adeline Matschulat; Cory R Reiter; Alanna Ritchie; Nicholas L Baird; Jeffrey L Bennett; Gregory P Owens
Journal:  Acta Neuropathol       Date:  2015-10-28       Impact factor: 17.088

6.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

7.  Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases.

Authors:  Martina Absinta; Irene C M Cortese; Luisa Vuolo; Govind Nair; Manori P de Alwis; Joan Ohayon; Alessandro Meani; Vittorio Martinelli; Roberta Scotti; Andrea Falini; Bryan R Smith; Avindra Nath; Steven Jacobson; Massimo Filippi; Daniel S Reich
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

8.  N4ITK: improved N3 bias correction.

Authors:  Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee
Journal:  IEEE Trans Med Imaging       Date:  2010-04-08       Impact factor: 10.048

9.  3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions.

Authors:  Emma C Tallantyre; Paul S Morgan; Jennifer E Dixon; Ali Al-Radaideh; Matthew J Brookes; Peter G Morris; Nikos Evangelou
Journal:  J Magn Reson Imaging       Date:  2010-10       Impact factor: 4.813

10.  CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.

Authors:  Markus C Kowarik; Sabine Cepok; Johann Sellner; Verena Grummel; Martin S Weber; Thomas Korn; Achim Berthele; Bernhard Hemmer
Journal:  J Neuroinflammation       Date:  2012-05-16       Impact factor: 8.322

View more
  12 in total

1.  Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis.

Authors:  S N Jonas; I Izbudak; A A Frazier; D M Harrison
Journal:  AJNR Am J Neuroradiol       Date:  2018-09-13       Impact factor: 3.825

2.  No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis.

Authors:  Mehrnaz Ighani; Samuel Jonas; Izlem Izbudak; Seongjin Choi; Alfonso Lema-Dopico; Jun Hua; Erin E O'Connor; Daniel M Harrison
Journal:  Mult Scler       Date:  2019-10-01       Impact factor: 6.312

3.  Sex-specific differences in rim appearance of multiple sclerosis lesions on quantitative susceptibility mapping.

Authors:  Tolaymat B; Zheng W; Chen H; Choi S; Li X; Harrison Dm
Journal:  Mult Scler Relat Disord       Date:  2020-06-18       Impact factor: 4.339

4.  Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.

Authors:  N Bergsland; D Ramasamy; E Tavazzi; D Hojnacki; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-14       Impact factor: 3.825

5.  Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury.

Authors:  Lesley A Ward; Dennis Sw Lee; Anshu Sharma; Angela Wang; Ikbel Naouar; Xianjie I Ma; Natalia Pikor; Barbara Nuesslein-Hildesheim; Valeria Ramaglia; Jennifer L Gommerman
Journal:  JCI Insight       Date:  2020-01-16

Review 6.  Epidemiology and treatment of multiple sclerosis in elderly populations.

Authors:  Caila B Vaughn; Dejan Jakimovski; Katelyn S Kavak; Murali Ramanathan; Ralph H B Benedict; Robert Zivadinov; Bianca Weinstock-Guttman
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

7.  Association of retinal atrophy with cortical lesions and leptomeningeal enhancement in multiple sclerosis on 7T MRI.

Authors:  Ryan Mizell; Hegang Chen; Jeffrey Lambe; Shiv Saidha; Daniel M Harrison
Journal:  Mult Scler       Date:  2021-06-14       Impact factor: 6.312

8.  Multiple Sclerosis in the Emirati Population: Onset Disease Characterization by MR Imaging.

Authors:  Manzoor Ahmed; Ruqqiya Mir; Mustafa Shakra; Safana Al Fardan
Journal:  Mult Scler Int       Date:  2019-11-25

Review 9.  Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice.

Authors:  Nicolo' Bruschi; Giacomo Boffa; Matilde Inglese
Journal:  Eur Radiol Exp       Date:  2020-10-22

Review 10.  CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review.

Authors:  Whitney M Freeze; Merel van der Thiel; Jeroen de Bresser; Catharina J M Klijn; Ellis S van Etten; Jacobus F A Jansen; Louise van der Weerd; Heidi I L Jacobs; Walter H Backes; Susanne J van Veluw
Journal:  Neuroimage Clin       Date:  2020-10-02       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.